SCHEMBL21154838

SCHEMBL21154838

CCOC(=O)c1cc(Br)c(CBr)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.44
CYP4A11 Q02928 1/20 0.44
TSHR P16473 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
JMJD6 Q6NYC1 1/20 0.40
CA1 P00915 6/20 0.40
CA2 P00918 6/20 0.40
CA9 Q16790 5/20 0.40
CA12 O43570 4/20 0.40
CA7 P43166 2/20 0.40
CA14 Q9ULX7 2/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAOB P27338 1/20 0.39
KMT2A Q03164 1/20 0.38
PDE3B Q13370 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31267876 0.88 CYP4F2 (0.44) CYP4F2CYP4A11TSHRKDM4ENPSR1
SCHEMBL366265 0.88 CYP4F2 (0.47) CYP4F2CYP4A11TSHRKDM4EJMJD6
SCHEMBL30595363 0.84 SOS1 (0.44) TSHRKDM4ENPSR1CA1CA2
SCHEMBL22400318 0.84 SOS1 (0.44) TSHRKDM4ENPSR1CA1CA2
SCHEMBL6858915 0.84 TSHR (0.47) CYP4F2CYP4A11TSHRKDM4ENPSR1
SCHEMBL17930513 0.83 TSHR (0.46) CYP4F2CYP4A11TSHRKDM4ENPSR1
SCHEMBL16530136 0.82 ALDH1A1 (0.47) CYP4F2CYP4A11TSHRKDM4ENPSR1
SCHEMBL25260946 0.81 TSHR (0.47) CYP4F2CYP4A11TSHRKDM4ENPSR1
SCHEMBL1729932 0.81 TSHR (0.45) CYP4F2CYP4A11TSHRKDM4ENPSR1
SCHEMBL21154860 0.80 TSHR (0.51) CYP4F2CYP4A11TSHRKDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019134680-A1 INHIBITOR OF APOPTOSIS SIGNAL-REGULATING KINASE-1 AND APPLICATION THEREOF 广州市恒诺康医药科技有限公司 2019-07-11 WO disclosed